Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
CALL
Ferguson
FERG
$47.4B
| $7.04M | ﹤0.01% |
+63,600
| New | +$7.7M |
|
3102
Core Alternative Capital
CCOR
$28.2M
| $7.04M | ﹤0.01% |
+229,514
| New | +$6.97M |
|
|
SAFM
3103
DELISTED
Sanderson Farms Inc
SAFM
| $7.03M | ﹤0.01% |
32,638
-4,715
| -13% | -$923K |
|
3104
Leslie's
LESL
$6.04M
| $7.03M | ﹤0.01% |
23,146
-9,974
| -30% | -$3.72M |
|
3105
Warby Parker
WRBY
$3.2B
| $7.02M | ﹤0.01% |
623,793
+346,574
| +125% | +$6.96M |
|
3106
abrdn Physical Palladium Shares ETF
PALL
$651M
| $7.02M | ﹤0.01% |
196,550
+190,615
| +3,212% | +$7.39M |
|
3107
CALL
Neurocrine Biosciences
NBIX
$15.5B
| $7.02M | ﹤0.01% |
72,000
+18,400
| +34% | +$1.7M |
|
3108
Assured Guaranty
AGO
$3.38B
| $7.01M | ﹤0.01% |
125,740
+16,079
| +15% | +$928K |
|
|
VTNR
3109
PUT
DELISTED
Vertex Energy, Inc
VTNR
| $7.01M | ﹤0.01% |
666,700
+292,300
| +78% | +$3.46M |
|
3110
Anavex Life Sciences
AVXL
$298M
| $7M | ﹤0.01% |
699,719
+471,144
| +206% | +$4.46M |
|
3111
iShares 10+ Year Investment Grade Corporate Bond ETF
IGLB
$2.78B
| $7M | ﹤0.01% |
131,385
-266,842
| -67% | -$14.8M |
|
3112
CALL
Lattice Semiconductor
LSCC
$18.5B
| $7M | ﹤0.01% |
144,400
-113,300
| -44% | -$5.64M |
|
3113
CALL
InMode
INMD
$872M
| $7M | ﹤0.01% |
312,300
-9,100
| -3% | -$239K |
|
3114
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
$1.74B
| $6.99M | ﹤0.01% |
234,958
+203,716
| +652% | +$6.43M |
|
|
MFA
3115
CALL
MFA Financial
MFA
$926M
| $6.99M | ﹤0.01% |
650,150
-23,750
| -4% | -$320K |
|
3116
PUT
Shake Shack
SHAK
$3.02B
| $6.99M | ﹤0.01% |
177,000
+48,400
| +38% | +$2.47M |
|
|
DALS
3117
DELISTED
DA32 Life Science Tech Acquisition Corp. Class A Common Stock
DALS
| $6.99M | ﹤0.01% |
720,941
+125,000
| +21% | +$1.22M |
|
|
USAK
3118
DELISTED
USA Truck Inc
USAK
| $6.97M | ﹤0.01% |
221,853
+196,196
| +765% | +$3.38M |
|
3119
Customers Bancorp
CUBI
$2.82B
| $6.96M | ﹤0.01% |
205,309
+126,367
| +160% | +$5.14M |
|
|
MRC
3120
DELISTED
MRC Global
MRC
| $6.95M | ﹤0.01% |
697,543
-207,904
| -23% | -$2.31M |
|
3121
CALL
Madison Square Garden
MSGS
$9.8B
| $6.95M | ﹤0.01% |
46,000
+3,500
| +8% | +$568K |
|
3122
PUT
Kulicke & Soffa
KLIC
$5.19B
| $6.94M | ﹤0.01% |
162,200
+107,500
| +197% | +$5.32M |
|
|
RETA
3123
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $6.94M | ﹤0.01% |
228,503
+99,660
| +77% | +$2.97M |
|
3124
Capitol Federal Financial
CFFN
$1.08B
| $6.93M | ﹤0.01% |
754,987
+205,010
| +37% | +$2.03M |
|
3125
Ocular Therapeutix
OCUL
$2.2B
| $6.93M | ﹤0.01% |
1,723,993
+31,657
| +2% | +$120K |
|
Similar funds
Citadel Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
- Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.